Abstract:OBJECTIVE:To transplant intravenously human brain-derived neurotrophic factor (hBDNF) gene-modified bone marrow mesenchymal stem cells (BMSCs) marked with enhanced green fluorescent protein (EGFP) to injured spinal cord of adult rats, then to observe the viability of the cells and the expressions of the gene in spinal cord, as well as the influence of neurological morphological repairing and functional reconstruction.METHODS:Ninety-six male SD rats weighing (250 +/- 20) g were randomly divided into 4 groups: hBDNF-EGFP-BMSCs transplantation group (group A, n = 24), Ad5-EGFP-BMSCs transplantation group (group B, n = 24), control group (group C, n = 24), and sham operation group (group D, n = 24). In groups A, B, and C, the spinal cord injury models were prepared according to the modified Allen method at the level of T10 segment, and after 3 days, 1 mL hBDNF-EGFP-BMSCs suspension, 1 mL Ad5-EGFP-BMSCs suspension and 1 mL 0.1 mol/L phosphate buffered saline (PBS) were injected into tail vein, respectively; in group D, the spinal cord was exposed without injury and injection. At 24 hours after injury and 1, 3, 5 weeks after intravenous transplantation, the structure and neurological function of rats were evaluated by the Basso-Beattie-Bresnahan (BBB) score, cortical somatosensory evoked potential (CSEP) and transmission electron microscope. The viability and distribution of BMSCs in the spinal cord were observed by fluorescent inverted phase contrast microscope and the level of hBDNF protein expression in the spinal cord was observed and analyzed with Western blot. Meanwhile, the expressions of neurofilament 200 (NF-200) and synaptophysin I was analyzed with immunohi stochemistry.RESULTS:After intravenous transplantation, the neurological function was significantly improved in group A. The BBB scores and CSEP in group A were significantly higher than those in groups B and C (P < 0.05) at 3 and 5 weeks. The green fluorescence expressions were observed at the site of injured spinal cord in groups A and B at 1, 3, and 5 weeks. The hBDNF protein expression was detected after 1, 3, and 5 weeks of intravenous transplantation in group A, while it could not be detected in groups B, C, and D by Western blot. The expressions of NF-200 and synaptophysin I were stronger and stronger with transplanting time in groups A, B, and C. The expressions of NF-200 and synaptophysin I were strongest at 5 weeks, and the expressions in group A were stronger than those in groups B and C (P < 0.05). And the expressions of NF-200 in groups A, B, and C were significantly stronger than those in group D (P < 0.05), whereas the expressions of synaptophysin I in groups A, B, and C were significantly weaker than those in group D (P < 0.05). Ultramicrostructure of spinal cords in group A was almost normal.CONCLUSION:Transplanted hBDNF-EGFP-BMSCs can survive and assemble at the injured area of spinal cord, and express hBDNF. Intravenous implantation of hBDNF-EGFP-BMSCs could promote the restoration of injured spinal cord and improve neurological functions.

Mechanism of bone mesenchymal stem cells transplantation promoting recovery of injured spinal cord

Bone Marrow Mesenchymal Stem Cells (bmscs) Improved Functional Recovery of Spinal Cord Injury Partly by Promoting Axonal Regeneration

Transplantation of Bone Marrow Mesenchymal Stem Cells Reduces Lesion Volume and Induces Axonal Regrowth of Injured Spinal Cord

Experimental study and short-term clinical follow-up of bone mesenchymal stem cells transplantation for repair of spinal cord injury

Spinal Cord Injury in Rats Treated Using Bone Marrow Mesenchymal Stem-Cell Transplantation.

Transplantation Of Bone Marrow Mesenchymal Stem Cells Inhibits Apoptosis In Injured Rat Spinal Cord

Repair of Spinal Cord Injury in Rats by Transplantation with Bone Marrow Mesenchymal Stem Cells and Stimulus of Direct Current

Improvement of neurological function in rats with spinal cord injury after the transplantation of neural stem cells directly differentiated from bone marrow mesenchymal stem cells

Thrombospondin-1 Modified Bone Marrow Mesenchymal Stem Cells (bmscs) Promote Neurite Outgrowth and Functional Recovery in Rats with Spinal Cord Injury.

Magnetic resonance imaging tracking and assessing repair function of the bone marrow mesenchymal stem cells transplantation in a rat model of spinal cord injury.

Mitochondrial Transfer from Bone Marrow Mesenchymal Stem Cells to Motor Neurons in Spinal Cord Injury Rats via Gap Junction.

Comparison of Neural Stem Cells and Bone Marrow Mesenchymal Stem Cells Transplantation for Spinal Cord Injury

The Survival and Differentiation of Bone Marrow Stromal Cells after Spinal Cord Injury in Rat with Intravenous Administration

Functional Recovery and Microenvironmental Alterations in A Rat Model of Spinal Cord Injury Following Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Transplantation

[Preliminary Study on Effects of Human Brain-Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells by Intravenous Transplantation on Structure and Function of Rat Injured Spinal Cord].

The treatment of spinal cord injury in rats using bone marrow-derived neural-like cells induced by cerebrospinal fluid

[Analysis of Chronergy for Treatment of Spinal Cord Injury with the Allogeneic Bone Mesenchymal Stem Cells (bmscs) Transplantation in Rats].

Experimental Study of Repairing Acute Spinal Cord Injury with Transplantation of Mesenchymal Stem Cells Genetically Modified by NGF in Rats

Effect of free NgR-modified bone marrow stromal cell transplantation on axon regeneration after spinal cord injury

Bone Marrow Mesenchymal Stem Cells Transplantation Combined with Exercise Training Synergistically Promoted Functional Recovery After Spinal Cord Injury.

Combination of Activated Schwann Cells with Bone Mesenchymal Stem Cells: the Best Cell Strategy for Repair after Spinal Cord Injury in Rats